by jlohrconsulting | Jul 23, 2025 | Uncategorized
J Adolesc Health. 2025 Jul 22:S1054-139X(25)00198-3. doi: 10.1016/j.jadohealth.2025.05.010. Online ahead of print. ABSTRACT PURPOSE: Global crises such as climate change, pandemics, and wars present significant challenges, particularly for children and adolescents in...
by jlohrconsulting | Jul 23, 2025 | Uncategorized
Int Clin Psychopharmacol. 2025 Jul 23. doi: 10.1097/YIC.0000000000000597. Online ahead of print. ABSTRACT This Phase 3, randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of lumateperone to treat bipolar depression. Patients (18-75...
by jlohrconsulting | Jul 23, 2025 | Uncategorized
Ann Hematol. 2025 Jul 22. doi: 10.1007/s00277-025-06516-6. Online ahead of print. ABSTRACT OBJECTIVE: The EORTC QLQ-CML24 questionnaire was developed and validated to enhance research in the health-related quality of life (HRQoL) of patients with chronic myeloid...
by jlohrconsulting | Jul 23, 2025 | Uncategorized
Surg Endosc. 2025 Jul 21. doi: 10.1007/s00464-025-11928-6. Online ahead of print. ABSTRACT BACKGROUND: Higher patient activation (PA) correlates with better surgical outcomes but there is little evidence supporting interventions to improve PA in surgical patients....
by jlohrconsulting | Jul 23, 2025 | Uncategorized
Discov Ment Health. 2025 Jul 22;5(1):108. doi: 10.1007/s44192-025-00255-w. ABSTRACT Geriatric depression is one of the most common mental disorders globally. The relationship between social participation and having depressive disorders can be considered as reciprocal....
by jlohrconsulting | Jul 23, 2025 | Uncategorized
Med Oncol. 2025 Jul 22;42(8):364. doi: 10.1007/s12032-025-02919-7. ABSTRACT Depressive symptoms are recognized contributors to breast cancer progression; while previous studies have investigated the role of antidepressants in breast cancer, their therapeutic potential...
Recent Comments